A recent study demonstrated the potential of dietary intervention to reduce stroke incidence by half by reducing systemic inflammation.
Aspirin Cuts Liver Fat in Preliminary MASLD Trial
Daily low-dose aspirin reduced hepatic fat in patients with noncirrhotic metabolic dysfunction-associated steatotic liver disease (MASLD), a randomized phase II trial showed. Among the 80